News >

Bekaii-Saab Brings Insight to Precision Medicine in GI Cancers

Brandon Scalea
Published: Wednesday, Jan 23, 2019

Tanios Bekaii-Saab, MD

Tanios Bekaii-Saab, MD
A precision medicine approach in oncology is entering nationwide clinics and across various tumor types, but many unanswered questions still remain before this strategy can apply to gastrointestinal (GI) cancer treatment, said Tanios Bekaii-Saab, MD.

For example, many patients with colorectal cancer (CRC) remain limited to traditional chemotherapy regimens, aside from a small population of those whose tumors are microsatellite instability-high (MSI-H). This rare subset can derive significant benefit from checkpoint inhibitors.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x